127 related articles for article (PubMed ID: 19399901)
1. Development of vaccination approaches for the treatment of neurological diseases.
Federoff HJ
J Comp Neurol; 2009 Jul; 515(1):4-14. PubMed ID: 19399901
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.
Neff F; Wei X; Nölker C; Bacher M; Du Y; Dodel R
Autoimmun Rev; 2008 Jun; 7(6):501-7. PubMed ID: 18558370
[TBL] [Abstract][Full Text] [Related]
3. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
Matsuda J; Kaminaka K; Nozaki C
Biochem Biophys Res Commun; 2009 Apr; 382(1):149-52. PubMed ID: 19265678
[TBL] [Abstract][Full Text] [Related]
5. Influence of conformational antibodies on dissociation of fibrillar amyloid beta (A beta 1-42) in vitro.
Subramanian S; Madhavadas S; Balasubramanian P
Indian J Exp Biol; 2009 May; 47(5):309-13. PubMed ID: 19579793
[TBL] [Abstract][Full Text] [Related]
6. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential?
Foster JK; Verdile G; Bates KA; Martins RN
Mol Psychiatry; 2009 Mar; 14(3):239-51. PubMed ID: 18957942
[TBL] [Abstract][Full Text] [Related]
7. [Neurodegenerative amyloidoses: the yeast model].
Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and therapeutic vaccination in CNS diseases.
Weiner HL; Selkoe DJ
Nature; 2002 Dec 19-26; 420(6917):879-84. PubMed ID: 12490962
[TBL] [Abstract][Full Text] [Related]
9. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
[TBL] [Abstract][Full Text] [Related]
10. Intrabody applications in neurological disorders: progress and future prospects.
Miller TW; Messer A
Mol Ther; 2005 Sep; 12(3):394-401. PubMed ID: 15964243
[TBL] [Abstract][Full Text] [Related]
11. Protein misfolding and neurodegeneration.
Soto C; Estrada LD
Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
[TBL] [Abstract][Full Text] [Related]
12. Vaccines for conformational disorders.
Sadowski M; Wisniewski T
Expert Rev Vaccines; 2004 Jun; 3(3):279-90. PubMed ID: 15176944
[TBL] [Abstract][Full Text] [Related]
13. Proteopathy: the next therapeutic frontier?
Walker LC; LeVine H
Curr Opin Investig Drugs; 2002 May; 3(5):782-7. PubMed ID: 12090553
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with Abeta-displaying virus-like particles reduces soluble and insoluble cerebral Abeta and lowers plaque burden in APP transgenic mice.
Bach P; Tschäpe JA; Kopietz F; Braun G; Baade JK; Wiederhold KH; Staufenbiel M; Prinz M; Deller T; Kalinke U; Buchholz CJ; Müller UC
J Immunol; 2009 Jun; 182(12):7613-24. PubMed ID: 19494285
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
Kanemaru K
Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
[TBL] [Abstract][Full Text] [Related]
16. Congo red and protein aggregation in neurodegenerative diseases.
Frid P; Anisimov SV; Popovic N
Brain Res Rev; 2007 Jan; 53(1):135-60. PubMed ID: 16959325
[TBL] [Abstract][Full Text] [Related]
17. Mechanical stress and formation of protein aggregates in neurodegenerative disorders.
Hachiya NS; Kozuka Y; Kaneko K
Med Hypotheses; 2008; 70(5):1034-7. PubMed ID: 17910993
[TBL] [Abstract][Full Text] [Related]
18. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele.
Zota V; Nemirovsky A; Baron R; Fisher Y; Selkoe DJ; Altmann DM; Weiner HL; Monsonego A
J Immunol; 2009 Sep; 183(5):3522-30. PubMed ID: 19675171
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic approaches for prion disorders.
Ludewigs H; Zuber C; Vana K; Nikles D; Zerr I; Weiss S
Expert Rev Anti Infect Ther; 2007 Aug; 5(4):613-30. PubMed ID: 17678425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
